Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-09-27 21:39:36
Reporting Period:
Accepted Time:
2017-09-27 21:39:36
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE Biological Products, (No Disgnostic Substances) (2836) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674528 L Paul Jenkinson C/o Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-25 2,500 $0.00 10,410 No 4 A Direct
Common Stock Disposition 2017-09-25 948 $179.66 9,462 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000 Indirect See footnote
  1. Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on August 18, 2017.
  2. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
  3. The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.